Zell Jason A, Ziogas Argyrios, Ignatenko Natalia, Honda Jane, Qu Ning, Bobbs Alexander S, Neuhausen Susan L, Gerner Eugene W, Anton-Culver Hoda
Department of Epidemiology, University of California, Irvine, California 92697, USA.
Clin Cancer Res. 2009 Oct 1;15(19):6208-16. doi: 10.1158/1078-0432.CCR-09-0592. Epub 2009 Sep 29.
Activity of ornithine decarboxylase (ODC), the first enzyme in polyamine synthesis, is required for normal growth and is elevated in many cancers, including colorectal cancer. We examined associations of the +316 ODC1 single nucleotide polymorphism (SNP) with colorectal cancer-specific survival among colorectal cancer cases, and then investigated its functional significance in colon cancer cells.
The study included 400 incident stage I-III colorectal cancer cases from the population-based University of California Irvine Gene-Environment Study of Familial Colorectal Cancer (diagnosed from 1994 to 1996 with follow-up through March 2008). The primary outcome was colorectal cancer-specific survival dependent on ODC1 (rs2302615) genotype (GG versus GA/AA). In human colon cancer cell lines, ODC1 allele-specific binding of E-box transcription factors was determined via Western blotting and chromatin immunoprecipitation assays. ODC1 allele-specific promoter activity was determined using promoter constructs in combination with vectors expressing either the transcriptional activator c-MYC or the repressor MAD1.
Genotype-specific survival differences were observed among colorectal cancer cases: compared with cases with the ODC1 GG genotype (hazards ratio, 1; reference) the adjusted colorectal cancer-specific survival hazards ratio was 2.02 (95% confidence interval, 1.17-3.50) for ODC1 GA/AA cases (P = 0.012). In colon cancer cells, the ODC1 SNP, flanked by two E-boxes, predicts ODC1 promoter activity. The E-box activator c-MYC and repressors MAD1 and MAD4 preferentially bind to ODC1 minor A-alleles, compared with major G-alleles, in cultured cells.
These results have implications for conditional regulation of polyamine homeostasis and suggest a model in which the ODC1 SNP may be protective for colon adenoma recurrence and detrimental for survival after colon cancer diagnosis.
鸟氨酸脱羧酶(ODC)是多胺合成的首个酶,其活性对于正常生长是必需的,且在包括结直肠癌在内的许多癌症中升高。我们研究了结直肠癌病例中ODC1基因 +316 单核苷酸多态性(SNP)与结直肠癌特异性生存的关联,随后在结肠癌细胞中研究了其功能意义。
该研究纳入了来自基于人群的加利福尼亚大学欧文分校家族性结直肠癌基因 - 环境研究的400例 I - III 期新发结直肠癌病例(1994年至1996年诊断,随访至2008年3月)。主要结局是依赖于ODC1(rs2302615)基因型(GG 与 GA/AA)的结直肠癌特异性生存。在人结肠癌细胞系中,通过蛋白质印迹法和染色质免疫沉淀试验确定ODC1等位基因特异性与E - 盒转录因子的结合。使用启动子构建体与表达转录激活因子c - MYC或阻遏蛋白MAD1的载体组合来确定ODC1等位基因特异性启动子活性。
在结直肠癌病例中观察到基因型特异性生存差异:与ODC1 GG基因型病例(风险比,1;参照)相比,ODC1 GA/AA病例的校正后结直肠癌特异性生存风险比为2.02(95%置信区间,1.17 - 3.50)(P = 0.012)。在结肠癌细胞中,两侧有两个E - 盒的ODC1 SNP可预测ODC1启动子活性。在培养细胞中,与主要的G等位基因相比,E - 盒激活因子c - MYC以及阻遏蛋白MAD1和MAD4优先与ODC1次要的A等位基因结合。
这些结果对多胺稳态的条件调节具有启示意义,并提示了一个模型,其中ODC1 SNP可能对结肠腺瘤复发具有保护作用,而对结肠癌诊断后的生存有害。